Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 13 results.
User Information
Export Records
  1. 1.   High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
  2. Ganesan, A.; Crum-Cianflone, N.; Higgins, J.; Qin, J.; Rehm, C.; Metcalf, J.; Brandt, C.; Vita, J.; Decker, C. F.; Sklar, P.; Bavaro, M.; Tasker, S.; Follmann, D.; Maldarelli, F.
  3. Journal of Infectious Diseases. 2011, Mar; 203(6): 756-764.
  1. 2.   Determination of the cyclic depsipeptide FK228 in human and mouse plasma by liquid chromatography with mass-spectrometric detection
  2. Chen, X. H.; Gardner, E. R.; Figg, W. D.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2008 865(1-2): 153-158.
  1. 3.   Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel
  2. Gardner, E. R.; Dahut, W. L.; Scripture, C. D.; Jones, J.; Aragon-Ching, J. B.; Desai, N.; Hawkins, M. J.; Sparreboom, A.; Figg, W. D.
  3. Clinical Cancer Research. 2008 14(13): 4200-4205.
  1. 4.   Cancer proteomics: many technologies, one goal
  2. Conrads, T. P.; Hood, B. L.; Petricoin, E. F.; Liotto, L. A.; Veenstra, T. D.
  3. Expert Review of Proteomics. 2005, Oct; 2(5): 693-703.
  1. 5.   Analysis of albumin-associated peptides and proteins from ovarian cancer patients
  2. Lowenthal, M. S.; Mehta, A. I.; Frogale, K.; Bandle, R. W.; Araujo, R. P.; Hood, B. L.; Veenstra, T. D.; Conrads, T. P.; Goldsmith, P.; Fishman, D.; Petricoin, E. F.; Liotta, L. A
  3. Clinical Chemistry. 2005, OCT; 51(10): 1933-1945.
  1. 6.   Investigation of the mouse serum proteome
  2. Hood, B. L.; Zhou, M.; Chan, K. C.; Lucas, D. A.; Kim, G. J.; Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.
  3. Journal of Proteome Research. 2005, SEP-OCT; 4(5): 1561-1568.
  1. 7.   Biomarkers: Mining the biofluid proteome
  2. Veenstra, T. D.; Conrads, T. P.; Hood, B. L.; Avellino, A. M.; Ellenbogen, R. G.; Morrison, R. S.
  3. Molecular & Cellular Proteomics. 2005 4(4): 409-418.
  1. 8.   Proteomic patterns for early cancer detection
  2. Veenstra, T. D.; Prieto, D. A.; Conrads, T. P.
  3. Drug Discovery Today. 2004, OCT 15; 9(20): 889-897.
  1. 9.   The human plasma proteome - A nonredundant list developed by combination of four separate sources
  2. Anderson, N. L.; Polanski, M.; Pieper, R.; Gatlin, T.; Tirumalai, R. S.; Conrads, T. P.; Veenstra, T. D.; Adkins, J. N.; Pounds, J. G.; Fagan, R.; Lobley, A.
  3. Molecular & Cellular Proteomics. 2004 3(4): 311-326.
  1. 10.   An investigation into the human serum "interactome"
  2. Zhou, M.; Lucas, D. A.; Chan, K. C.; Issaq, H. J.; Petricoin, E. F.; Liotta, L. A.; Veenstra, T. D.; Conrads, T. R.
  3. Electrophoresis. 2004 25(9): 1289-1298.
  1. 11.   Characterization of the low molecular weight human serum proteome
  2. Tirumalai, R. S.; Chan, K. C.; Prieto, D. A.; Issaq, H. J.; Conrads, T. P.; Veenstra, T. D.
  3. Molecular & Cellular Proteomics. 2003 2(10): 1096-1103.
  1. 12.   Serum protein fingerprinting
  2. Veenstra, T. D.; Conrads, T. P.
  3. Current Opinion in Molecular Therapeutics. 2003 5(6): 584-593.
  1. 13.   Evaluation of a fluorogenic derivatization method for the reversed-phase HPLC analysis of 2 '-beta-fluoro-2 ',3 '- dideoxyadenosine, a new anti-AIDS drug
  2. Zhang, H. P.; Ford, H.; Roth, J. S.; Kelley, J. A.
  3. Journal of Pharmaceutical and Biomedical Analysis. 2001 25(2): 285-297.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel